Ambrx Biopharma Inc

AMAM

Market cap $1.77B

Delisted

AMAM was delisted on the 6th of March, 2024.

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	1 Fidelity Investments Boston, Massachusetts	$68.7M	+$64.2M	+3,766,940	New
2	CAM 2 Cormorant Asset Management Boston, Massachusetts	$47M	+$42.4M	+2,486,386	New
3	FI 3 Fosun International Hong Kong, China	$37.9M	+$32.9M	+1,932,591	New
4	4 Adage Capital Partners Boston, Massachusetts	$35.8M	+$31.1M	+1,827,292	New
5	SCM 5 Suvretta Capital Management New York	$22.9M	+$19.9M	+1,169,529	New
6	6 BlackRock New York	$16.7M	+$14.5M	+850,676	New
7	AG 7 Artal Group Luxembourg	$16.7M	+$14.5M	+850,000	New
8	OCA 8 Octagon Capital Advisors New York	$8.82M	+$7.67M	+450,000	New
9	9 Millennium Management New York	$2.82M	+$2.46M	+144,092	New
10	MIM 10 Monashee Investment Management Boston, Massachusetts	$2.16M	+$1.87M	+110,000	New
11	11 AllianceBernstein Nashville, Tennessee	$1.37M	+$1.19M	+70,000	New
12	12 Norges Bank Oslo, Norway	$1.37M	+$1.19M	+70,000	New
13	13 Tudor Investment Corp Stamford, Connecticut	$1.18M	+$1.02M	+60,000	New
14	CCM 14 CAAS Capital Management New York	$784K	+$682K	+40,000	New
15	GCM 15 Ghisallo Capital Management Boston, Massachusetts	$784K	+$682K	+40,000	New
16	MWNA 16 Marshall Wace North America New York	$640K	+$556K	+32,648	New
17	PHP 17 Parkman Healthcare Partners Stamford, Connecticut	$294K	+$256K	+15,000	New
18	BFM 18 Boothbay Fund Management New York	$263K	+$229K	+13,422	New
19	PCM 19 Pinz Capital Management New York	$20K	+$17K	+1,000	New
20	20 Bank of America Charlotte, North Carolina	$2K	+$1.88K	+110	New